BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Sep 23, 2022
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Purchase
Common Stock
2022-09-22$2.10/sh+10,000$21,042→ 1,040,000 total
Holdings
- 24,940(indirect: By LLC)
Common Stock